Skip to main content

Day: April 6, 2021

HIGHCO : Transactions sur Actions propres du 29/03/21 au 02/04/21

Déclaration des transactions sur actions propresRéalisées du 29 mars au 2 avril 2021 Paris, le 6 avril 2021 Présentation agrégée par jour et par marchéNom de l’émetteur Code identifiant émetteur Jour de la transaction Code identifiant de l’instrument financier Volume total journalier(en nombre d’actions) Prix pondéré moyen journalier d’acquisition des actions MarchéHIGH CO 969500FYLNRXCJ348W66 29/03/2021 FR 0000054231 1 000 5,68 € XPARHIGH CO 969500FYLNRXCJ348W66 30/03/2021 FR 0000054231 1 000 5,73 € XPARHIGH CO 969500FYLNRXCJ348W66 31/03/2021 FR 0000054231 1 000 5,72 € XPARHIGH CO 969500FYLNRXCJ348W66 01/04/2021 FR 0000054231 1 000 5,67 € XPARPrésentation détaillée transaction par transaction  Code identifiant PSI JourHeure de la transaction Code identifiant de l’instrument financier Prix unitaire (unité) Devise Quantité...

Continue reading

Almadex Provides Update on Exploration and Royalty Portfolio

VANCOUVER, British Columbia, April 06, 2021 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: “DEX”) is pleased to provide an update on activities commenced and planned for the coming year at its mineral properties in British Columbia, Nevada, and Mexico. Duane Poliquin, Chairman of Almadex, stated “We expect 2021 to be an exciting year for Almadex. Several of our directly owned and optioned properties could be drilled this year, pending receipt of the necessary permits and allocation of budgets by some of our partners. At the same time, there are some exciting developments in our royalty portfolio, which continues to advance. Almadex has the necessary funds to execute on its 2021 exploration plans.” Additional detail on the Company’s mineral property and royalty assets is provided...

Continue reading

PCI Biotech to present at European Biotech Investor Days 2021

Oslo (Norway), 6 April 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing innovative therapeutics that address significant unmet medical needs in cancer today announced that it will present at the European Biotech Investor Days 2021, a US based online event taking place April 7-8, 2021 and hosted by Goodwin, Solebury Trout, Deutsche Bank and Nasdaq. On Thursday, April 8, 2021 at 15:00 (CEST), Dr. Per Walday, CEO, will present an overview of PCI Biotech’s proprietary platform technology via a general company presentation. The presentation can be accessed live through this link https://showroom.troutaccess.com/app?iframe=1#/webcast/GHAQ5D  The presentation slides will be made available on PCI Biotech’s website (www.pcibiotech.com) under “Other presentations” after the event. Contact information:    Per Walday,...

Continue reading

HEXO launches first of its kind Bake Sale value brand

OTTAWA, April 06, 2021 (GLOBE NEWSWIRE) — HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NYSE: HEXO) is proud to launch its latest brand, Bake Sale. Bake Sale offers Canadian consumers one of the lowest prices per gram in the country, in some cases as much as 20% less than competitor’s products. The first of its kind, Bake Sale was created for value seekers and is ideally suited for cannabis cooking consumers who are perfecting recipes or experimenting with decarboxylation and infused food for the first time. The affordable large-format products also offer consumers convenience and the ability to blend with and extend their higher potency product to extend their current stash. “Bake Sale is HEXO’s latest market disruptor,” said HEXO CEO and co-founder, Sebastien St-Louis. “The brand’s low price point and approachable potency should...

Continue reading

HEXO lance Bake Sale, une marque avantageuse première en son genre

OTTAWA, 06 avr. 2021 (GLOBE NEWSWIRE) — HEXO Corp (« HEXO », ou la « Société ») (TSX : HEXO ; NYSE : HEXO) est fière de lancer sa toute dernière marque, Bake Sale. Bake Sale offre aux consommateurs canadiens l’un des prix au gramme les plus bas du pays, allant dans certains cas jusqu’à 20 % de moins par rapport aux produits de la concurrence. Première du genre, Bake Sale a été créée pour les personnes qui recherchent un bon rapport qualité-prix et convient parfaitement aux consommateurs qui cuisinent avec du cannabis, qui perfectionnent leurs recettes, ou qui expérimentent pour la première fois avec la décarboxylation et les aliments infusés. Les produits abordables en grand format offrent également aux consommateurs la commodité et la possibilité de les intégrer aux produits plus puissants afin de maximiser leur réserve...

Continue reading

PureGold Drilling Returns High Grades Including 56.6 g/t Gold Over 1.0 Metres

VANCOUVER, British Columbia., April 06, 2021 (GLOBE NEWSWIRE) — Pure Gold Mining Inc. (TSX-V: PGM, LSE:PUR) (“PureGold” or the “Company”), is pleased to report high grade drill intercepts returned from underground drilling completed during the first quarter of 2021. This drilling targeted zones in close proximity to new ramp development and adjacent to planned stoping areas with the goal of expanding available reserves and increasing grades in the near-term mine plan. As underground development at the PureGold Mine continues to progress rapidly toward commercial production and unlock access to high grade ore, these positive results highlight the clear path to significantly improve the already strong mine plan over the next 12 months.1 Underground drilling results highlights:56.6 g/t gold over 1.0 metre from drill hole PGB-0186; 8.7...

Continue reading

Amarin Commences Commercial Initiatives for VAZKEPA in European Union Following Recent Regulatory Approval for Cardiovascular Risk Reduction Indication

Reimbursement dossiers for first 10 countries to be filed in coming months 150 people hired and on-track to be deployed by mid-Q2 2021 supplemented by digital outreach and medical education programs with initial top priority on Germany VAZKEPA commercial launch in Germany planned for Q3 2021 DUBLIN, Ireland and BRIDGEWATER, N.J., April 06, 2021 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today provided updates regarding its plans for the commercial launch of VAZKEPA (icosapent ethyl) in Europe following the March 30, 2021 announcement of receipt of market authorization from the European Commission (EC). VAZKEPA is the first EC-approved product to be marketed and sold for cardiovascular risk reduction in high-risk, statin-treated adult patients who have elevated triglycerides (≥150 mg/dL) and other risk characteristics...

Continue reading

Rubicon Organics Reports Fourth Quarter 2020 Financial Results and Operational Milestones

Earned $4.8 million of net revenue in Q4 2020, an increase of 51% over Q3 2020VANCOUVER, British Columbia., April 06, 2021 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (“Rubicon Organics” or the “Company”) (TSXV:ROMJ | OTCQX:ROMJF), a licensed producer focused on cultivating and selling organic certified and premium cannabis, today reported its financial results for the fourth quarter and year ended December 31, 2020 (“Q4 2020”). All amounts are expressed in Canadian dollars. “Our focused strategy of producing the highest quality premium organic cannabis is gaining more traction as we launch new products, add brands and expand distribution. We are very pleased with the $9.4 million in net revenue we delivered in 2020, our first year of operation, and we believe that our expanded distribution and deep innovation pipeline will continue...

Continue reading

Victoria Gold: Eagle Gold Mine Q1 2021 Operational Highlights

WHITEHORSE, Yukon, April 06, 2021 (GLOBE NEWSWIRE) — Victoria Gold Corp. (TSX-VGCX) (“Victoria” or the “Company”) produced 26,759 ounces of gold during the first quarter of 2021. Mr. John McConnell, President and CEO commented, “During the first quarter, we have successfully completed the winter maintenance and upgrade program, continued to irrigate the heap leach pad and pour gold and resumed stacking ore on the heap leach pad earlier than planned. The Company has initiated a COVID-19 vaccination program at the Eagle site and effective health protection measures continue, with no suspected or confirmed cases of COVID-19.” Eagle Gold Mine First Quarter 2021 Operational Highlights The Company’s seasonal operations plan for 2021 included curtailment of ore stacking on the heap leach pad during the 90 coldest days of the year, January...

Continue reading

The Ensign Group Acquires Three Skilled Nursing Facilities in Colorado

SAN JUAN CAPISTRANO, Calif., April 06, 2021 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and speech therapies and other rehabilitative and healthcare services, announced today that it acquired the operations of the following skilled nursing facilities in Colorado:Boulder Canyon Health and Rehabilitation, a 140-bed skilled nursing facility located in Boulder, CO; Berthoud Care and Rehabilitation, a 76-bed skilled nursing facility located in Berthoud, CO; and South Valley Post Acute Rehabilitation, a 106-bed skilled nursing facility located in Denver, CO.These acquisitions were effective April 1, 2021 and will be subject to a long-term, triple net lease. “We are pleased...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.